[A clinico-experimental study in metronomic therapy of disseminated solid tumors] [0.03%]
Meta周期方案治疗播散性实体瘤的临床及实验研究
V A Chudenko,V M Moiseenko
V A Chudenko
Although medication of malignancies made a considerable progress and the rates of apparent response grew markedly, those of survival among patients with disseminated solid tumors increased insignificantly. Metronomic therapy with cytostatic...
A G Bazhenov,K D Guseĭnov,A V Khadzhimba et al.
A G Bazhenov et al.
The investigation involved 285 patients suffering from recurrences and distant metastases of uterine carcinoma cases of 24% of all (primary tumor). All recurrences generally occurred 12-20 months after the beginning of specialized therapy i...
[Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma] [0.03%]
[评估芳香化酶抑制剂用于子宫内膜癌新辅助治疗有效性的标准]
L M Bershteĭn,M A Danilova,A Iu Kovalevskiĭ et al.
L M Bershteĭn et al.
Clinical and experimental effects of neoadjuvant treatment of endometrial cancer patients with non-steroidal aromatase inhibitors: letrozole (femara, n=10, 2.5 mg/day, 14 days), anastrozole (arimidex, n=15,1 mg/day, 28 days) and exemestane ...
Comparative Study
Voprosy onkologii. 2009;55(3):314-8. DOI: 2009
[Quality of life of patients with breast cancer receiving hormonal therapy, depending on age and marital status] [0.03%]
不同年龄及婚姻状态接受内分泌治疗的乳腺癌患者生存质量分析
E A Trishikina,R V Orlova,L D Roman
E A Trishikina
Our study involved 247 patients with histologically verified breast tumors, aged 48-89, who had received hormones - tamoxifen as first-line therapy, exemestan (second-line) for 12 months. FACT-B and FACT-G questionnaires were used to assess...
[Should neoadjuvant therapy be performed for nodular breast cancer stage II-III, and if so, by which modality?] [0.03%]
[nodecjuvant治疗在乳腺导管内癌中的应用指征及选择]
V M Efetov,I N Dylenok
V M Efetov
In order to choose optimal preoperative treatment for nodular breast cancer stage II-III (T1-4N0-2M0), potentials of neoadjuvant polychemotherapy and large-fraction radiotherapy were compared (464). Groups of patients were formed by random ...
Comparative Study
Voprosy onkologii. 2009;55(3):305-9. DOI: 2009
[The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives] [0.03%]
[用于癌症预防的肽生物调节剂的应用：35年研究经验的结果和展望]
V N Anisimov,V Kh Khavinson
V N Anisimov
Review
Voprosy onkologii. 2009;55(3):291-304. DOI: 2009
[Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness] [0.03%]
生活质量作为局部进展期前列腺癌治疗有效性的评价指标
A D Kaprin,A A Kostin,A D Tsybul&#x;skiĭ
A D Kaprin
Review
Voprosy onkologii. 2009;55(3):285-90. DOI: 2009
[Ductal cytometry of urinary sediment in the diagnosis of bladder cancer] [0.03%]
尿沉渣导管细胞学在膀胱癌诊断中的应用价值分析
B K Bozhenko,A D Kaprin,T M Kulinich et al.
B K Bozhenko et al.
Review
Voprosy onkologii. 2009;55(3):278-84. DOI: 2009
Z G Kadagidze,A I Chertkova,E G Slavina
Z G Kadagidze
Review
Voprosy onkologii. 2009;55(3):269-77. DOI: 2009
A V Vorob&#x;ëv
A V Vorob&#x;ëv